Kirkland & Ellis Helps Linden Buy SeraCare For $82M

Law360, New York (February 13, 2012, 12:44 PM EST) -- SeraCare Life Sciences Inc. will be purchased by Chicago-based private equity firm Linden Capital Partners in a deal worth $82 million, the Massachussetts-based medical diagnostics company said Monday.

SeraCare common shareholders will receive $4 per share, a 25 percent premium on the volume-weighted average stock price over the past month, according to the definitive agreement cementing the deal.

"SeraCare's commitment to providing vital products and services of the highest quality has driven our growth and diversification across a blue chip life sciences customer base," interim president,...
To view the full article, register now.